Accuray Announces CEO Medical Leave and Interim Successor
Company Announcements

Accuray Announces CEO Medical Leave and Interim Successor

The latest announcement is out from Accuray (ARAY).

Suzanne Winter, CEO of Accuray Incorporated, will be on medical leave starting September 3, 2024. Sandeep Chalke, previously the Chief Commercial Officer, steps in as the interim CEO. With extensive experience in the medical device industry and leadership roles at notable companies, Chalke’s salary and bonus are adjusted to reflect his new responsibilities. This change was announced in a press release and detailed in a regulatory filing.

For detailed information about ARAY stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAccuray Incorporated Reports Strong Start to Fiscal 2025
TipRanks Auto-Generated NewsdeskAccuray Inc. Optimistic Despite Revenue Decline
TheFlyAccuray reports Q1 EPS (4c), consensus (5c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App